In March 2025, the company introduced new plans for any direct-to-purchaser providing of its Wegovy weight loss drug. The company proven a fresh pharmacy, termed NovoCare, which would charge shoppers $499 per month for entry to the drug, under fifty percent the cost of the drug by way of other pharmaceutical distribution networks.[53]This led Novo